Evaluation of Clinical outcomes among non-valvular atrial fibrillatIon patients with renal dysfunction treated with warfarin or reduced dose rivaroxaban (CALLIPER)

28/11/2017
02/07/2024
EU PAS number:
EUPAS21253
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

OS_Protocol_RenalDysfunction_MarketScan_v5

English (297.71 KB - PDF) View document
Updated protocol

19721_Study Protocol_V2.0_Redacted

First published: 22/02/2024
English (885.39 KB - PDF) View document
Study results
Study results

19721_CALLIPER_EU PAS Abstract_2019-07-31_Redacted

English (221.14 KB - PDF) View document
Study report
Study report

19721_CALLIPER_Clinical Study Report_2019-07-31_Redacted

English (9.89 MB - PDF) View document
Other information